Comparison of Androgen Receptor, VEGF, HIF-1, Ki67 and MMP9 Expression Between Non-Metastatic and Metastatic Stages in Stromal and Tumor Cells of Oral Squamous Cell Carcinoma

Overview

Journal Life (Basel)

Specialty Biology

Date 2021 Apr 30

PMID 33920263

Citations 9

Authors

Lovorka Batelja-Vuletic

cedna Tomasovic-Loncaric

Marcello Ceppi

Marco Bruzzone

Aleksandra Fucic

Karolina Krstanac

Vanja Boras Vucicevic

Affiliations

Soon will be listed here.

Abstract

Objectives: Oral squamous cell carcinoma (OSCC) is the most common oral malignancy with low survival as it is very often diagnosed at an advanced stage, which is why the accurate profiling of the tumor is essential. The aim of this study was to, for the first time, compare in OSCC the frequency of AR, VEGF, MMP9, HiF1beta and Ki67 between the non-metastatic and metastatic disease.

Materials And Methods: In the study, 96 non-metastatic and 91 metastatic OSCC patients were analysed for AR, VEGF, MMP9, HiF1beta and Ki67 levels by immunohistochemistry.

Results: All of the tested biomarkers significantly differed between non-metastatic and metastatic disease. A significant association was found between >/=20% AR positive epithelium cells in cytoplasm, Ki67 and VEGF in cancer stroma. Ki67, HiF1beta, VEGF and MMP9 were significantly associated with TNM stages.

Conclusion: Our results show for the first time an interplay between AR, VEGF, MMP9, HiF1beta and Ki67 in OSCC which may contribute to better diagnostics and therapy selection.

Citing Articles

Dysregulated LINC01133 expression in laryngeal carcinoma: Prognostic implications and predicted ceRNA interactome.

Razipour M, Jamali Z, Sohrabpour S, Heidari F, Lotfi M, Ghadami E Mol Biol Res Commun. 2025; 14(1):93-107.

PMID: 39744510 PMC: 11624609. DOI: 10.22099/mbrc.2024.50390.1996.

A novel nomogram model based on Ki-67 characteristic expression to predict prognosis in head and neck squamous cell carcinoma.

Wang T, Xue L, Li Z, Hong Z, Hu N, Li Y Front Oncol. 2024; 14:1376498.

PMID: 38651151 PMC: 11033387. DOI: 10.3389/fonc.2024.1376498.

Expression Status of Rap1 Pathway-Related Genes in Liver Metastases Compared with Corresponding Primary Colorectal Cancer.

Abbastabar M, Allgayer H, Sepidarkish M, Sadeghi F, Ghasemi M, Pour-Bagher R Cancers (Basel). 2024; 16(1).

PMID: 38201598 PMC: 10778515. DOI: 10.3390/cancers16010171.

Prodigiosin/celecoxib-loaded into zein/sodium caseinate nanoparticles as a potential therapy for triple negative breast cancer.

Mohamed W, El-Nekhily N, Mahmoud H, Hussein A, Sabra S Sci Rep. 2024; 14(1):181.

PMID: 38168547 PMC: 10761898. DOI: 10.1038/s41598-023-50531-4.

Cyclin D1 and Ki-67 expression and its correlation with histopathological parameters and cervical lymph node metastasis in oral squamous cell carcinoma.

Khalesi S, Maleki L, Eskandari S, Dehabadi F, Kohpaee A Dent Res J (Isfahan). 2023; 20:112.

PMID: 38020247 PMC: 10680078.

References

Shigetomi S, Imanishi Y, Shibata K, Sakai N, Sakamoto K, Fujii R . VEGF-C/Flt-4 axis in tumor cells contributes to the progression of oral squamous cell carcinoma via upregulating VEGF-C itself and contactin-1 in an autocrine manner. Am J Cancer Res. 2018; 8(10):2046-2063. PMC: 6220132. View

Mabjeesh N, Willard M, Frederickson C, Zhong H, Simons J . Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells. Clin Cancer Res. 2003; 9(7):2416-25. View

Yuan J, Li W, Zhu J, Deng S, Tao X . Low expression of RECK in oral squamous cell carcinoma patients induces a shorter survival rate through an imbalance of RECK/MMPs. Int J Clin Exp Pathol. 2020; 13(3):501-508. PMC: 7136997. View

Tomasovic-Loncaric C, Fucic A, Andabak A, Andabak M, Ceppi M, Bruzzone M . Androgen Receptor as a Biomarker of Oral Squamous Cell Carcinoma Progression Risk. Anticancer Res. 2019; 39(8):4285-4289. DOI: 10.21873/anticanres.13593. View

Hu C, Fang D, Xu H, Wang Q, Xia H . The androgen receptor expression and association with patient's survival in different cancers. Genomics. 2019; 112(2):1926-1940. DOI: 10.1016/j.ygeno.2019.11.005. View

Oliveira L, Ribeiro-Silva A . Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2011; 40(3):298-307. DOI: 10.1016/j.ijom.2010.12.003. View

Koyfman S, Ismaila N, Crook D, DCruz A, Rodriguez C, Sher D . Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol. 2019; 37(20):1753-1774. PMC: 7098829. DOI: 10.1200/JCO.18.01921. View

Eckert A, Wickenhauser C, Salins P, Kappler M, Bukur J, Seliger B . Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma. J Transl Med. 2016; 14:85. PMC: 4820994. DOI: 10.1186/s12967-016-0828-6. View

Modjtahedi H . Molecular therapy of head and neck cancer. Cancer Metastasis Rev. 2005; 24(1):129-46. DOI: 10.1007/s10555-005-5052-4. View

10.

Karagiannis G, Poutahidis T, Erdman S, Kirsch R, Riddell R, Diamandis E . Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res. 2012; 10(11):1403-18. PMC: 4399759. DOI: 10.1158/1541-7786.MCR-12-0307. View

11.

Adamo B, Ricciardi G, Ieni A, Franchina T, Fazzari C, Sano M . The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer. Oncotarget. 2017; 8(44):76974-76986. PMC: 5652756. DOI: 10.18632/oncotarget.20293. View

12.

DArcangelo E, Wu N, Cadavid J, McGuigan A . The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome. Br J Cancer. 2020; 122(7):931-942. PMC: 7109057. DOI: 10.1038/s41416-019-0705-1. View

13.

Liu L, Chen J, Cai X, Yao Z, Huang J . Progress in targeted therapeutic drugs for oral squamous cell carcinoma. Surg Oncol. 2019; 31:90-97. DOI: 10.1016/j.suronc.2019.09.001. View

14.

Lombardi A, Vicente C, Porto C . Estrogen Receptors Promote Migration, Invasion and Colony Formation of the Androgen-Independent Prostate Cancer Cells PC-3 Through β-Catenin Pathway. Front Endocrinol (Lausanne). 2020; 11:184. PMC: 7160699. DOI: 10.3389/fendo.2020.00184. View

15.

Taghavi N, Yazdi I . Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Arch Iran Med. 2015; 18(5):314-9. DOI: 0151805/AIM.0010. View

16.

Choi J, Jang Y, Min S, Song J . Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic Conditions. J Breast Cancer. 2011; 14(2):88-95. PMC: 3148536. DOI: 10.4048/jbc.2011.14.2.88. View

17.

Larsson P, Syed Khaja A, Semenas J, Wang T, Sarwar M, Dizeyi N . The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer. Int J Cancer. 2019; 146(6):1686-1699. PMC: 7004098. DOI: 10.1002/ijc.32607. View

18.

Jimenez L, Jayakar S, Ow T, Segall J . Mechanisms of Invasion in Head and Neck Cancer. Arch Pathol Lab Med. 2015; 139(11):1334-48. PMC: 7469951. DOI: 10.5858/arpa.2014-0498-RA. View

19.

Lin J, Li X, Tadashi N, Dong P . Clinical significance of tumor-associated macrophage infiltration in supraglottic laryngeal carcinoma. Chin J Cancer. 2011; 30(4):280-6. PMC: 4013355. DOI: 10.5732/cjc.010.10336. View

20.

Goulioumis A, Varakis J, Goumas P, Papadaki H . Androgen receptor in laryngeal carcinoma: could there be an androgen-refractory tumor?. ISRN Oncol. 2011; 2011:180518. PMC: 3236417. DOI: 10.5402/2011/180518. View